Grifols SA (GRFS)
6.39
-0.40
(-5.89%)
USD |
NASDAQ |
May 02, 16:00
6.38
-0.01
(-0.16%)
After-Hours: 20:00
Grifols Net Income (Quarterly): 60.30M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 60.30M |
| September 30, 2023 | 64.83M |
| June 30, 2023 | 65.46M |
| December 31, 2022 | 20.52M |
| September 30, 2022 | 44.89M |
| June 30, 2022 | 96.23M |
| June 30, 2021 | 164.97M |
| March 31, 2021 | 156.57M |
| December 31, 2020 | 158.41M |
| September 30, 2020 | 312.74M |
| June 30, 2020 | 35.10M |
| March 31, 2020 | 205.68M |
| December 31, 2019 | 223.40M |
| September 30, 2019 | 151.80M |
| June 30, 2019 | 193.80M |
| March 31, 2019 | 129.92M |
| December 31, 2018 | 146.44M |
| September 30, 2018 | 173.62M |
| June 30, 2018 | 209.64M |
| March 31, 2018 | 176.17M |
| December 31, 2017 | 271.95M |
| September 30, 2017 | 180.93M |
| June 30, 2017 | 158.29M |
| March 31, 2017 | 142.74M |
| December 31, 2016 | 150.34M |
| Date | Value |
|---|---|
| September 30, 2016 | 158.10M |
| June 30, 2016 | 157.26M |
| March 31, 2016 | 138.17M |
| December 31, 2015 | 142.82M |
| September 30, 2015 | 155.70M |
| June 30, 2015 | 146.99M |
| March 31, 2015 | 144.98M |
| December 31, 2014 | 163.94M |
| September 30, 2014 | 151.28M |
| June 30, 2014 | 142.45M |
| March 31, 2014 | 165.73M |
| December 31, 2013 | 106.88M |
| September 30, 2013 | 111.66M |
| June 30, 2013 | 119.90M |
| March 31, 2013 | 120.14M |
| December 31, 2012 | 76.98M |
| September 30, 2012 | 79.82M |
| June 30, 2012 | 84.70M |
| March 31, 2012 | 88.54M |
| December 31, 2011 | 8.776M |
| September 30, 2011 | 34.66M |
| June 30, 2011 | -20.71M |
| March 31, 2011 | 46.02M |
| December 31, 2010 | 25.11M |
| September 30, 2010 | 39.54M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
20.52M
Minimum
Dec 2022
312.74M
Maximum
Sep 2020
130.31M
Average
151.80M
Median
Sep 2019
Net Income (Quarterly) Benchmarks
| DBV Technologies SA | -11.19M |
| Adaptimmune Therapeutics PLC | -47.92M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | -9.507M |
| Biophytis SA | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.906B |
| Total Expenses (Quarterly) | 1.812B |
| EPS Diluted (Quarterly) | 0.0888 |
| Enterprise Value | 15.95B |
| Gross Profit Margin (Quarterly) | 38.98% |
| Profit Margin (Quarterly) | 3.16% |
| Earnings Yield | 4.87% |
| Operating Earnings Yield | 18.53% |
| Normalized Earnings Yield | 3.336 |